Aehr Test Systems (AEHR) Stock Price & Analysis
Aehr Test Systems (AEHR) fell 13.77% to USD 76.32 as of July 25, 2026 at 01:45 UTC, according to Nexqual real-time market data.
AEHR last closed at USD 88.51; the session ranged USD 75.51–87.46 on volume of 2,707,721 shares. Market capitalization is $2.48B, with a 52-week range of USD 15.94–126.62 (NCM). Source: Nexqual, July 25, 2026 at 01:45 UTC.
Key Statistics (as of July 25, 2026 at 01:45 UTC)
| Price | USD 76.32 |
|---|---|
| Change | ▼ 13.77% (down) |
| Previous Close | USD 88.51 |
| Open | USD 87.32 |
| Day Range | USD 75.51 – 87.46 |
| 52-Week Range | USD 15.94 – 126.62 |
| Volume | 2,707,721 shares |
| Market Cap | $2.48B |
| Exchange | NCM |
Technical Analysis (AEHR)
Nexqual's technical model rates AEHR "STRONG SELL" based on 0 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 01:45 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 44.95 (neutral) |
| vs SMA50 | Below (USD 93.17) |
| MACD | -2.19 (negative) |
Analyst Ratings (AEHR)
Wall Street analysts rate AEHR "Strong Buy" based on 3 analysts, with a mean price target of USD 115 (range USD 110–125), per Nexqual as of July 25, 2026 at 01:45 UTC.
| Consensus Rating | Strong Buy |
|---|---|
| Analyst Count | 3 |
| Mean Target | USD 115 |
| High Target | USD 125 |
| Low Target | USD 110 |
| Buy / Hold / Sell | 4 / 0 / 0 |
Earnings (AEHR)
| Next Earnings Date | 2026-10-08 |
|---|---|
| EPS Estimate | USD 0.09 |
| Revenue Estimate | $26.61M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-05-31 | USD 0.11 vs est -0.01 ▲ beat |
| 2026-02-28 | USD -0.05 vs est -0.07 ▲ beat |
| 2025-11-30 | USD -0.04 vs est -0.04 ▼ miss |
| 2025-08-31 | USD 0.01 vs est 0 ▲ beat |
Source: Nexqual, July 25, 2026 at 01:45 UTC.
Financials & Fundamentals (AEHR)
| Total Revenue | $50.00M |
|---|---|
| Revenue Growth (YoY) | +33.70% |
| Gross Margin | +38.50% |
| Operating Margin | -4.24% |
| Profit Margin | -14.25% |
| ROE | -4.16% |
| Debt / Equity | 4.5 |
| Current Ratio | 10.33 |
| Total Cash | $116.36M |
| Total Debt | $9.88M |
| Free Cash Flow | $-955,375 |
Source: Nexqual, July 25, 2026 at 01:45 UTC.
Financial Health Score (AEHR)
Nexqual rates Aehr Test Systems's overall financial health "Weak" across five dimensions, as of July 25, 2026 at 01:45 UTC.
| Growth | Critical — Revenue -15% YoY (annual), sharp decline |
|---|---|
| Profitability | Weak — Gross margin 39%, operating -4% |
| Balance Sheet | Strong — $116M cash vs $10M debt, net cash position |
| Cash Flow | Weak — FCF negative: -$955K, burning cash |
| Efficiency | Critical — ROE -4%, ROA -4.0% |
Ownership (AEHR)
| Insider Ownership | +4.68% |
|---|---|
| Institutional Ownership | +71.72% |
| Shares Outstanding | 32.48M |
| Float | 30.96M |
| Short % of Float | +13.98% |
Source: Nexqual, July 25, 2026 at 01:45 UTC.
Leadership (AEHR)
Aehr Test Systems is led by Gayn Erickson (age 61), President, CEO & Director, per Nexqual as of July 25, 2026 at 01:45 UTC.
| President, CEO & Director | Gayn Erickson (age 61) |
|---|---|
| Founder & Independent Chairman | Rhea J. Posedel (age 83) |
| CFO, Executive VP of Finance & Secretary | Chris P. Siu (age 54) |
| Chief Operating Officer | Adil Engineer (age 48) |
| Chief Technology Officer | Donald P. Richmond (age 69) |
Major Backers & Investors (AEHR)
Notable institutional backers of Aehr Test Systems include FMR, LLC, Price (T.Rowe) Associates Inc, AWM Investment Company, Inc., according to Nexqual as of July 25, 2026 at 01:45 UTC.
Active Investors
| Investor | Stake |
|---|---|
| FMR, LLC | 6.81% |
| Price (T.Rowe) Associates Inc | 5.5% |
| AWM Investment Company, Inc. | 5.07% |
| Fidelity | 4.15% |
| Goldman Sachs | 4.01% |
| Baillie Gifford | 3.18% |
| T. Rowe Price | 2.6% |
| Next Century Growth Investors LLC | 2.4% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 13.23% |
| BlackRock | 9.5% |
Source: Nexqual, July 25, 2026 at 01:45 UTC.
From Aehr Test Systems's Latest SEC 10-K Filing (filed 2025-07-28)
Key Strengths & Strategy (as disclosed to the SEC)
- We have developed and introduced several innovative products including the FOX-P TM family of test and burn-in systems and FOX WaferPak TM Aligner, FOX WaferPak Contactor, FOX DiePak® Carrier and FOX DiePak Loader.
- The Company's strategy is to use in-house manufacturing only when necessary to protect a proprietary process or when a significant improvement in quality, cost or lead time can be achieved and relies on subcontractors to manufacture many of the components and subassemblies used in its products.
- As of May 30, 2025, the Company held 131 active patents in the United States, Singapore, China, Japan, Korea, and other countries, with expiration date ranges from 2025 to 2045, and had several additional United States patent applications and foreign patent applications pending.     The Company's ability to compete successfully is dependent in part upon its ability to protect its proprietary technology and information.
- Our technology and architectural design allow our products to take up only 5% of the test floor space compared to competitor's products.   The Company improved its facilities by replacing existing air conditioners and heat exchanger with higher efficiency units that draw less power and produce less wasted energy.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| AXTI | AXT Inc | USD 47.23 | ▼ 10.85% |
| AAOI | Applied Optoelectronics, Inc. | USD 100.15 | ▼ 9.38% |
| CRDO | Credo Technology Group Holding | USD 213.15 | ▼ 6.62% |
| NVTS | Navitas Semiconductor Corporati | USD 10.92 | ▼ 13.81% |
| ACLS | Axcelis Technologies, Inc. | USD 134.1 | ▼ 5.53% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 01:45 UTC. This page is informational and not investment advice.